This study is conducted under the AIDS Clinical Trials Group (ACTG) and funded by the U.S. National Institutes of Health.
This is a prospective, double-blind, randomized, placebo-controlled, multicenter efficacy study in 6500 subjects, with individual subjects to be followed...